| 000 | 01648 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514001745.0 | ||
| 264 | 0 | _c20010621 | |
| 008 | 200106s 0 0 eng d | ||
| 022 | _a1525-4135 | ||
| 024 | 7 |
_a10.1097/00126334-200104150-00004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCoull, J J | |
| 245 | 0 | 0 |
_aA pilot study of the use of mycophenolate mofetil as a component of therapy for multidrug-resistant HIV-1 infection. _h[electronic resource] |
| 260 |
_bJournal of acquired immune deficiency syndromes (1999) _cApr 2001 |
||
| 300 |
_a423-34 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xpharmacology |
| 650 | 0 | 4 | _aCD4 Lymphocyte Count |
| 650 | 0 | 4 |
_aDrug Resistance, Microbial _xgenetics |
| 650 | 0 | 4 |
_aDrug Resistance, Multiple _xgenetics |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMycophenolic Acid _xanalogs & derivatives |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 |
_aRNA, Viral _xblood |
| 650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aSalvage Therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aTurner, D | |
| 700 | 1 | _aMelby, T | |
| 700 | 1 | _aBetts, M R | |
| 700 | 1 | _aLanier, R | |
| 700 | 1 | _aMargolis, D M | |
| 773 | 0 |
_tJournal of acquired immune deficiency syndromes (1999) _gvol. 26 _gno. 5 _gp. 423-34 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00126334-200104150-00004 _zAvailable from publisher's website |
| 999 |
_c11321903 _d11321903 |
||